An Expedited Code Stroke Protocol Is Feasible and Safe
- 1 December 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 37 (12), 2935-2939
- https://doi.org/10.1161/01.str.0000249057.44420.4b
Abstract
Stroke recovery critically depends on timely reperfusion. In July 2003, we set a benchmark onset-to-treatment time of < or =2 hours and instituted an expedited code stroke protocol to accomplish this. We aim to show that the protocol is feasible and safe. The expedited protocol includes: Benchmark onset-to-treatment within 2 hours; in-person triage of all code stroke patients; unmixed tissue plasminogen activator at the bedside during evaluation; no delays pending coagulation tests, chest x-ray, or stool guiac unless specifically indicated; and no delays pending formal CT interpretation or written consent. Between July 2003 and June 2005, we evaluated 781 patients and treated 103 of 781 (13.2%) with intravenous recombinant tissue plasminogen activator within 3 hours. Of these, we treated 49 of 103 (47.6%) within 2 hours of symptom onset, and 54 of 103 (52.4%) between 2 and 3 hours. The overall risk of symptomatic intracerebral hemorrhage was 4 of 103 (3.9%; 95% CI, 1.1%, 9.6%), and not significantly different from 6.4% (P=0.42). The hemorrhage risks in those treated within 2 hours of symptom onset and those treated between 2 and 3 hours were not significantly different from each other or from 6.4%. The expedited code stroke protocol is feasible and appears safe. Further study is warranted to confirm its safety and determine whether it results in better clinical outcomes.This publication has 14 references indexed in Scilit:
- Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness StudyCMAJ : Canadian Medical Association Journal, 2005
- The rt-PA for Acute Stroke ProtocolPublished by Springer Science and Business Media LLC ,2005
- Prehospital Neuroprotective Therapy for Acute StrokeStroke, 2004
- Guidelines for the Early Management of Patients With Ischemic StrokeStroke, 2003
- Intravenous Tissue-Type Plasminogen Activator Therapy for Ischemic StrokeArchives of Neurology, 2001
- Early stroke treatment associated with better outcomeNeurology, 2000
- Use of Tissue-Type Plasminogen Activator for Acute Ischemic StrokeJama-Journal Of The American Medical Association, 2000
- Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom OnsetJama-Journal Of The American Medical Association, 1999
- Tissue Plasminogen Activator for Acute Ischemic StrokeThe New England Journal of Medicine, 1995
- Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Hemispheric StrokePublished by American Medical Association (AMA) ,1995